Abeona Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Abeona Therapeutics has a total shareholder equity of $45.8M and total debt of $18.7M, which brings its debt-to-equity ratio to 40.7%. Its total assets and total liabilities are $120.6M and $74.8M respectively.
Key information
40.7%
Debt to equity ratio
US$18.65m
Debt
| Interest coverage ratio | n/a |
| Cash | US$109.70m |
| Equity | US$45.77m |
| Total liabilities | US$74.82m |
| Total assets | US$120.59m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PCJ's short term assets ($112.7M) exceed its short term liabilities ($18.4M).
Long Term Liabilities: PCJ's short term assets ($112.7M) exceed its long term liabilities ($56.4M).
Debt to Equity History and Analysis
Debt Level: PCJ has more cash than its total debt.
Reducing Debt: PCJ's debt to equity ratio has increased from 0% to 40.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PCJ has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if PCJ has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.